FDA-Approved Peptides in 2026: The Maintained List
"What peptides are FDA approved?" is a question with a precise answer that most pages get wrong, because they blur three different statuses: peptides approved as drugs, peptides that may be legally compounded under a prescription, and peptides sold in the gray market with no legal pathway for human use at all. This page keeps the three lists separate, is dated, and gets refreshed as FDA's positions move — because in the peptide world, an undated list is a wrong list. Last reviewed: September 19, 2026. This is general information, not medical or legal advice.
Key takeaways
- Dozens of peptide drugs hold full FDA approval — from GLP-1s like semaglutide and tirzepatide to tesamorelin, bremelanotide, and setmelanotide — and are legal nationwide by prescription.
- The most-hyped wellness peptides (BPC-157, TB-500, CJC-1295, ipamorelin, melanotan II) are not FDA-approved drugs; their availability, if any, runs through compounding eligibility rules that FDA has actively tightened through 2025–2026.
- "FDA-approved" and "legally available" are different questions: an unapproved peptide can still be legally compounded for an individual patient when it sits on the right FDA list, and an approved peptide can still be illegal to buy from a research-chem site.
- For programs and brands, the operational requirement is a pharmacy partner that tracks FDA's bulk-substance and shortage lists in real time — formularies in this category are living documents.
Peptide drugs with full FDA approval (by category)
These are approved drugs: FDA-reviewed for safety and efficacy, manufactured under CGMP, legal with a prescription in all 50 states.
| Category | Peptide (brand examples) | Notes |
|---|---|---|
| Metabolic / weight | Semaglutide (Ozempic, Wegovy, Rybelsus); Tirzepatide (Mounjaro, Zepbound); Liraglutide (Victoza, Saxenda) | The engines of modern weight-loss telehealth; see our compounded tirzepatide vs Zepbound guide |
| Genetic obesity | Setmelanotide (Imcivree) | Specific genetic indications |
| HIV-associated lipodystrophy | Tesamorelin (Egrifta) | A GHRH analog with full approval |
| Sexual health | Bremelanotide (Vyleesi) | Approved for HSDD in premenopausal women |
| Bone health | Teriparatide (Forteo); Abaloparatide (Tymlos) | PTH-related peptides |
| GI | Linaclotide (Linzess); Plecanatide (Trulance); Teduglutide (Gattex) | |
| Endocrine / oncology support | Octreotide (Sandostatin); Lanreotide (Somatuline); Leuprolide (Lupron); Goserelin (Zoladex) | Long-established |
| Hormones & classics | Insulin and analogs; Desmopressin; Oxytocin; Calcitonin | The original peptide drugs |
| Other notable | Glatiramer (Copaxone); Ziconotide (Prialt); Enfuvirtide (Fuzeon) | Diverse indications |
The list above is representative of the categories founders and patients actually search, not an exhaustive pharmacopeia; new approvals are added at review time.
Popular wellness peptides that are NOT FDA-approved
The peptides that dominate longevity podcasts and gym conversations are, almost uniformly, not approved drugs:
| Peptide | Marketed for | Status (as of Sept 2026) |
|---|---|---|
| BPC-157 | Healing, gut, joints | Not FDA-approved; FDA has placed it in unfavorable compounding categories and warned sellers; widely sold gray-market — see Are Peptides Legal? |
| TB-500 (thymosin beta-4 fragment) | Recovery | Not approved; research-market product |
| CJC-1295 / Ipamorelin | GH stimulation | Not approved; compounding eligibility has been under FDA scrutiny |
| Sermorelin | GH stimulation | The original approved product was discontinued; today prescribed via compounding where eligible |
| Melanotan II | Tanning, libido | Not approved; subject of explicit FDA/health-agency warnings |
| GHK-Cu | Skin, hair | Cosmetic-route products exist; not an approved drug for systemic use |
| Epitalon, and most "longevity" peptides | Anti-aging | Not approved; research-market products |
Not-approved does not always mean not-available: some of these have moved in and out of legitimate compounded availability depending on FDA's bulk-substance list positions — that's the middle status the next section explains. But bought from a "research use only" website, none of them is a lawful product for human use.
The middle category: compounded under prescription
Between "approved drug" and "gray market" sits legal compounding: a licensed prescriber writes an individual prescription, and a state-licensed 503A pharmacy prepares it — lawful when the peptide is eligible under FDA's current compounding framework (503A vs 503B explained). Three things matter about this category in 2026:
- Eligibility is list-driven and has been actively changing. FDA has recategorized several popular peptides through 2025–2026, and pharmacies differ in how aggressively they read the rules.
- The prescription is not a formality. Legitimate programs run real clinical intake and decline inappropriate patients.
- Program formularies must be living documents. What a brand could offer last quarter may differ this quarter — the operational argument for infrastructure with multi-pharmacy routing and real-time list tracking, covered in our peptide business guide and in our comparison of the best white label telehealth platforms.
What this means for patients and for brands
Patients: if a peptide matters to you, the legal route is a licensed provider and a licensed pharmacy — telehealth makes that accessible in all 50 states. If a website sells it without a prescription, it is not a legal source, whatever the label says.
Brands and clinics: build your peptide program on the approved + compounding-eligible lists, with clinician-governed formularies and a pharmacy network that flags list changes before they become compliance problems. That stack — 1,240+ board-certified providers, OrbitRx e-prescribing via Surescripts, LegitScript-certified compounding partners tracking FDA lists — is exactly what MyOrbitHealth operates under your brand (peptides solution page).
Frequently asked questions
What peptides are FDA approved?
Dozens of peptide drugs hold full approval, including semaglutide, tirzepatide, liraglutide, tesamorelin, bremelanotide, setmelanotide, teriparatide, linaclotide, octreotide, leuprolide, and classics like insulin and desmopressin. The wellness peptides popular online — BPC-157, TB-500, CJC-1295, ipamorelin, melanotan II — are not FDA-approved drugs.
Is BPC-157 FDA approved?
No. BPC-157 has never been approved as a drug, and FDA has taken unfavorable positions on its compounding eligibility and warned sellers marketing it for human use. Products sold online as research chemicals are not lawful for human consumption.
Can non-approved peptides still be prescribed?
Sometimes, through compounding: when a peptide is eligible under FDA's current compounding framework, a licensed provider can prescribe it for an individual patient and a licensed 503A pharmacy can prepare it. Eligibility shifts with FDA's lists, which is why dated, maintained information matters.
How often does this list change?
FDA approvals are added occasionally, but compounding-eligibility positions have shifted multiple times per year through 2025–2026. This page carries a last-reviewed date and is refreshed on a recurring schedule; treat any undated peptide list on the internet as unreliable.
Build on the right list
The difference between a peptide brand and a peptide problem is which list your formulary is built on. MyOrbitHealth's clinical network and pharmacy partners keep formularies on the legal side of FDA's moving lines — under your brand, in all 50 states. Book a demo.